Articles from BWX Technologies, Inc.

BWXT Canada, Ltd. (“BWXT”), a subsidiary of BWX Technologies, Inc., and Westinghouse Electric Company announced today that they have signed a memorandum of understanding (MOU) to support nuclear new-build projects in Canada and globally. Under the agreement, BWXT has the potential to manufacture key AP1000® and AP300™ reactor components, including steam generators, reactor vessels, pressure vessels and heat exchangers.

BWX Technologies, Inc. (NYSEBWXT) is pleased to announce an award from the U.S. Department of Energy for cleanup operations at the West Valley Demonstration Project in West Valley, New York.

BWX Technologies, Inc. (NYSEBWXT) ("BWXT", "we", "us" or the "Company") reported third quarter 2024 results. A reconciliation of non-GAAP results are detailed in Exhibit 1.

BWX Technologies, Inc. (NYSEBWXT) today announced the opening of the John D. Haynes School of Welding Technology at Mount Vernon High School in Mount Vernon, Indiana. The company, along with the U.S. Navy and the BlueForge Alliance, have invested $500,000 into the new school to help further the educational journeys of students interested in pursuing a career in welding.

BWX Technologies, Inc. (NYSEBWXT) is pleased to announce that Hanford Tank Waste Operations & Closure, LLC (H2C) has been approved by the U.S. Department of Energy (DOE) to begin the Hanford Integrated Tank Disposition Contract (ITDC).

BWX Technologies, Inc. (NYSEBWXT) today announced that its Nuclear Fuel Services, Inc. (NFS) subsidiary was selected by the U.S. Department of Energy (DOE) as one of the successful bidders for High-Assay Low-Enriched Uranium (HALEU) deconversion services to support the civil advanced reactor marketplace.

BWX Technologies, Inc. (NYSEBWXT) will issue a press release detailing third quarter 2024 results on Monday, November 4, 2024, after market close and will host a conference call at 5:00 p.m. EST.

BWX Technologies, Inc., the parent company of Nuclear Fuel Services (NFS), today announced a $100,000 donation to the Unicoi County United Way to support the recovery efforts underway in the Erwin, Tennessee community. This contribution will directly support emergency response teams on the ground, helping to provide essential supplies, medical aid, shelter and long-term recovery services to those affected by this devastating event.

BWX Technologies, Inc. (NYSEBWXT) today announced a contract from the National Nuclear Security Administration (NNSA) to complete a yearlong engineering study to evaluate options for the deployment of a centrifuge pilot plant that would establish a domestic uranium enrichment capability for national security purposes.

BWX Technologies, Inc. (NYSEBWXT) has appointed Vittorio Puppo as president of BWXT Medical Ltd., effective August 12, 2024. In his new role, Puppo will focus on advancing the business’ mission to deliver high-quality nuclear medical products and solutions that improve patient outcomes worldwide.

BWX Technologies, Inc. (NYSEBWXT) ("BWXT", "we", "us" or the "Company") reported second quarter 2024 results. A reconciliation of non-GAAP results are detailed in Exhibit 1.

BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc. (NYSEBWXT) and NorthStar Medical Radioisotopes, LLC (NorthStar) today announced that they have signed a Master Services Agreement (MSA), which will facilitate the production of actinium-225 (Ac-225), a critical medical isotope used to kill cancer cells while minimizing the impact to healthy tissues.

BWX Technologies, Inc. (NYSEBWXT) will issue a press release detailing second quarter 2024 results on Monday, August 5, 2024, after market close and will host a conference call at 5:00 p.m. EDT.

BWX Technologies, Inc. (NYSEBWXT) today announced the award of the second phase of a contract with the Wyoming Energy Authority to assess the viability of deploying small-scale nuclear reactors in the state as a source of resilient and reliable energy to augment existing power generation resources.

BWX Technologies, Inc. (NYSEBWXT) today announced a contract award from the U.S. Department of Energy, National Nuclear Security Administration (DOE/NNSA) for management and operations of the Pantex Plant. Following an initial term of five years, NNSA has the ability to award three additional five-year option periods. If all contract options are exercised, the contract will span 20 years at a funding level of approximately $30 billion.

BWXT Medical Ltd. has submitted a Drug Master File (DMF) to the U.S. Drug and Food Administration (FDA) for No Carrier Added (n.c.a.) Actinium-225 (Ac-225) Active Pharmaceutical Ingredient.

BWX Technologies, Inc. (NYSEBWXT) ("BWXT", "we", "us" or the "Company") reported first quarter 2024 results. A reconciliation of non-GAAP results are detailed in Exhibit 1.

BWXT Canada Ltd., a subsidiary of BWX Technologies, Inc. (NYSEBWXT), has been selected as the first qualified supply chain company to join the GE Vernova nuclear business’ supplier group that will advance the global deployment of the BWRX-300 small modular reactor (SMR). The purpose of the supplier group is to ensure a reliable, cost effective and innovative process for the manufacture and commercialization of the BWRX-300 currently under design by GE Vernova’s nuclear business, GE Hitachi Nuclear Energy (GEH).

BWX Technologies, Inc. (NYSEBWXT) announced today an investment to expand its Cambridge manufacturing plant. Already one of the largest nuclear commercial manufacturing facilities in North America, the site’s increased footprint will enable greater capacity to support ongoing and anticipated customers’ investments in Small Modular Reactors, traditional large-scale nuclear and advanced reactors, in Canada and around the world.

BWX Technologies, Inc. (NYSEBWXT) announced today that it and Rolls-Royce have secured funding for Phase 2 of the UK Space Agency’s International Bilateral Fund (IBF). The funding enables strategic research collaborations within the UK space sector and emerging space nations to work together on fission nuclear systems for space power missions.

BWX Technologies, Inc. (NYSEBWXT) will issue a press release detailing first quarter 2024 results on Monday, May 6, 2024, after market close and will host a conference call at 5:00 p.m. EDT.

BWX Technologies, Inc. (NYSEBWXT) has released its 2024 Sustainability Report, demonstrating the company’s role in good governance, environmental stewardship, the ongoing global clean-energy transition, global security, investment in the communities where we operate, and many other initiatives critical to corporate social responsibility (CSR) excellence.

BWX Technologies, Inc. (NYSEBWXT) today announced a contract with an estimated value of up to $45 billion over a 10-year ordering period from the U.S. Department of Energy (DOE) for environmental management operations at the Hanford Site in Washington.

BWX Technologies, Inc. (NYSEBWXT) is hosting an Investor Day with financial analysts and institutional investors today, February 28, 2024, at 8:30 a.m. to approximately 11:30 a.m. ET.

BWX Technologies, Inc. (NYSEBWXT) ("BWXT", "we", "us" or the "Company") reported fourth quarter and full year 2023 results. A reconciliation of non-GAAP results are detailed in Exhibit 1.

BWX Technologies, Inc. (NYSEBWXT) will issue a press release detailing fourth quarter and full-year 2023 results on Tuesday, February 27, 2024 after market close and will host a conference call at 5:00 p.m. EST.

BWX Technologies, Inc. (NYSEBWXT) announced today that Nicole W. Piasecki has been appointed to its board of directors effective January 2, 2024.

BWX Technologies, Inc. (NYSEBWXT) today announced that it will host an Investor Day with financial analysts and institutional investors on Wednesday, February 28, 2024.

BWXT Medical Ltd. and Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) today announced that the companies have entered into an agreement for the supply of generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.

BWX Technologies, Inc. (NYSEBWXT) today announced that it has been selected as the nuclear fuel and components manufacturer for the Air Force Research Laboratory’s Joint Emergent Technology Supplying On-Orbit Nuclear (JETSON) high power mission application program, which will mature high-power nuclear electric power and propulsion technologies and spacecraft design.

BWX Technologies, Inc. (NYSEBWXT) ("BWXT", "we", "us" or the "Company") reported third quarter 2023 GAAP net income attributable to BWXT of $60.3 million, or diluted earnings per share (EPS) of $0.66, on third quarter revenues of $590.0 million. Third quarter 2023 non-GAAP(1) net income attributable to BWXT was $61.5 million, or non-GAAP(1) diluted EPS of $0.67. Third quarter 2023 adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA)(1) was $106.5 million. A reconciliation of non-GAAP results are detailed in Exhibit 1.

BWX Technologies, Inc. (NYSEBWXT) today announced the award of a U.S. Naval Nuclear Propulsion Program contract totaling approximately $300 million for the manufacture of naval nuclear reactor fuel.

BWX Technologies, Inc. (NYSEBWXT) will issue a press release detailing third quarter 2023 results on Wednesday, November 1, 2023, after market close and will host a conference call at 5:00 p.m. EDT.

Global shipping and energy supply chain leader Crowley has teamed with BWX Technologies, Inc. (NYSEBWXT) through a memorandum of understanding for a ship concept that has the potential to generate alternative, zero-carbon emission energy for defense and disaster needs by including a microreactor on board.

BWX Technologies, Inc. (NYSEBWXT) today announced a two-phase, two-year contract with the Wyoming Energy Authority to assess the viability of deploying small-scale nuclear reactors in the state as a source of resilient and reliable energy to augment existing power generation resources.

BWX Technologies, Inc. (NYSEBWXT) today announced a contract to process thousands of kilograms of government-owned scrap material containing enriched uranium that is unusable in its present form in order to produce more than two metric tons of feedstock that can be used for fuel to demonstrate advanced reactors and help decarbonize the U.S. power grid.

BWX Technologies, Inc. (NYSEBWXT) ("BWXT", "we", "us" or the "Company") reported second quarter 2023 GAAP net income attributable to BWXT of $58.6 million, or diluted earnings per share (EPS) of $0.64, on second quarter revenues of $612.4 million. Second quarter 2023 non-GAAP(1) net income attributable to BWXT was $59.4 million, or non-GAAP(1) diluted EPS of $0.65. Second quarter 2023 adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA)(1) was $107.0 million. A reconciliation of non-GAAP results are detailed in Exhibit 1.

BWX Technologies, Inc. (NYSEBWXT) today announced a contract with TerraPower to design the Intermediate Heat Exchanger for the Natrium Demonstration Project.

BWX Technologies, Inc. (NYSEBWXT) today announced that its reactor and fuel will be key components in the world’s first demonstration spacecraft using nuclear thermal propulsion.

BWX Technologies, Inc. (BWXT) (NYSEBWXT) will issue a press release detailing second quarter 2023 results on Thursday, August 3, 2023, after market close and will host a conference call at 5:00 p.m. EDT.

BWX Technologies, Inc. (NYSEBWXT) ("BWXT", "we", "us" or the "Company") reported first quarter 2023 GAAP net income attributable to BWXT of $61.1 million, or diluted earnings per share (EPS) of $0.67, on revenue of $568.4 million. First quarter 2023 non-GAAP(1) net income attributable to BWXT was $64.1 million, or $0.70 diluted EPS. First quarter 2023 adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA)(1) was $110.7 million. A reconciliation of non-GAAP results are detailed in Exhibit 1.

BWX Technologies, Inc. (NYSEBWXT) today announced a contract with an estimated value of up to $45 billion over a 10-year ordering period from the U.S. Department of Energy (DOE) for environmental management operations at the Hanford Site in Washington.

BWX Technologies, Inc. (NYSEBWXT) announced today that its Nuclear Fuel Services, Inc. (NFS) subsidiary has been awarded a $428 million contract from the National Nuclear Security Administration (NNSA) to provide purification and conversion services for highly enriched uranium (HEU).

BWX Technologies, Inc. (BWXT) (NYSEBWXT) will issue a press release detailing first quarter 2023 results on Monday, May 8, 2023, after market close and will host a conference call at 5:00 p.m. EDT.

BWX Technologies, Inc. (NYSEBWXT) today announced an engineering contract awarded by GE Hitachi Nuclear Energy (GEH) for its BWRX-300 small modular reactor (SMR) reactor pressure vessel (RPV).

BWX Technologies, Inc. (NYSEBWXT) has released its 2023 Sustainability Report, demonstrating the company’s deep involvement in environmental restoration, clean energy, global security, community investment and many other initiatives critical to environmental, social and governance (ESG) excellence.

BWX Technologies, Inc. (NYSEBWXT) ("BWXT", "we", "us" or the "Company") reported fourth-quarter and full-year 2022 results. A reconciliation of non-GAAP results are detailed in Exhibit 1.

Life-saving Molybdenum-99 (Mo-99) isotopes can now be produced at Ontario Power Generation’s (OPG) Darlington Nuclear Generating Station, thanks to the installation and initial commissioning of an innovative isotope system by Laurentis Energy Partners and BWXT Medical Ltd. (NYSEBWXT).

BWX Technologies, Inc. (BWXT) (NYSEBWXT) will issue a press release detailing fourth quarter and full-year 2022 results on Thursday, February 23, 2023, after market close and will host a conference call at 5:00 p.m. EST.

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), and BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc. (NYSEBWXT), today announced that the companies have entered into a preferred partner agreement for the supply of actinium-225. Under the agreement, BWXT Medical will provide predetermined amounts of Fusion’s actinium supply needs at volume-based pricing.

BWX Technologies, Inc. (NYSEBWXT) has promoted Ronald O. (Chip) Whitford, Jr. to the position of senior vice president, general counsel, chief compliance officer and corporate secretary, effective January 2, 2023. Whitford is succeeding Thomas E. McCabe, who will serve as special advisor to the CEO until his retirement on August 1, 2023.

BWX Technologies, Inc. (NYSEBWXT) today with officials from the U.S. Department of Defense, Department of Energy, NASA and Idaho National Laboratory celebrated the landmark production of TRISO nuclear fuel that will power the first microreactor built and operated in the United States.

BWX Technologies, Inc. (NYSEBWXT) ("BWXT", "we", "us" or the "Company") reported third quarter 2022 GAAP net income attributable to BWXT of $61.6 million, or diluted earnings per share (EPS) of $0.67, on revenue of $523.7 million. Third quarter 2022 non-GAAP(1) net income attributable to BWXT was $63.0 million, or $0.69 diluted EPS. Third quarter 2022 adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA)(1) was $100.1 million. A reconciliation of non-GAAP results are detailed in Exhibit 1.

BWX Technologies, Inc. (NYSEBWXT) announced today that management will be participating and presenting at three upcoming investor conferences before the end of the year.

BWX Technologies, Inc. (NYSEBWXT) announced today that it has closed on an amended and restated credit agreement with Wells Fargo Bank, N.A. and other lenders that increases the company’s liquidity while improving a number of key terms for BWXT.

BWX Technologies, Inc. (BWXT) (NYSEBWXT) will issue a press release detailing third quarter 2022 results on Monday, November 7, 2022, after market close and will host a conference call at 5:00 p.m. EST.

BWX Technologies, Inc. (NYSEBWXT) announced today that subsidiary BWXT Medical Ltd. has submitted a new drug application to the U.S. Food and Drug Administration (FDA) to request approval of its technetium-99m (Tc-99m) generator for diagnostic imaging.

BWX Technologies, Inc. (NYSEBWXT) has appointed Robert (Bob) Duffy as senior vice president and chief administrative officer (CAO). In this role, he will have full responsibility for human resources and a number of other business support functions.

BWX Technologies, Inc. (NYSEBWXT) ("BWXT", "we", "us" or the "Company") reported second quarter 2022 revenue of $554 million, a 10% increase compared with $505 million in the second quarter 2021. GAAP net income for the second quarter 2022 was $74.6 million, or $0.82 per diluted share, compared with net income of $59.3 million, or $0.62 per diluted share, in the prior-year period. Non-GAAP(1) net income for the second quarter 2022 was $75.4 million, or $0.82 per diluted share. Adjusted EBITDA(1) for the second quarter 2022 was $114.7 million, a 26% increase compared with $90.8 million in the prior-year period, primarily driven by higher revenue, the timing of certain long lead material production and positive site performance. A reconciliation of non-GAAP(1) results are detailed in Exhibit 1.

BWX Technologies, Inc. (NYSEBWXT) has appointed Sharon H. Smoot as president of BWXT’s Nuclear Operations Group, Inc. (NOG). In this role, she will have full responsibility for NOG’s mission to provide a complete range of nuclear components and services, including the manufacture of nuclear reactor components for U.S. Navy submarines and aircraft carriers and other nuclear and non-nuclear R&D and component production.

BWX Technologies, Inc. (BWXT) (NYSEBWXT) will issue a press release detailing second quarter 2022 results on Monday, August 8, 2022, after market close and will host a conference call at 5:00 p.m. EDT.

BWX Technologies, Inc. (NYSEBWXT) today announced a contract awarded by Bruce Power valued at approximately CA$130 million in support of Bruce Power’s Major Component Replacement (MCR) Project.

BWX Technologies, Inc. (NYSEBWXT) announced today that subsidiary BWXT Medical Ltd. has executed a commercial agreement with Bayer AG (Bayer) to supply high-purity Actinium-225 (Ac-225).

BWX Technologies, Inc. (NYSEBWXT) announced today that subsidiary BWXT Medical Ltd. and TRIUMF, Canada’s particle accelerator centre, have executed a licensing and services agreement that strengthens their existing partnership for the production of medical isotopes. This agreement will enable BWXT Medical to manufacture high purity Actinium-225 (Ac-225) based products for pharmaceutical companies as it continues to build on its medical isotope production operations on the TRIUMF site.

BWX Technologies, Inc. (NYSEBWXT) will build the first advanced nuclear microreactor in the United States under a contract awarded by the U.S. Department of Defense (DoD) Strategic Capabilities Office (SCO). The Project Pele full-scale transportable microreactor prototype will be completed and delivered in 2024 for testing at the Idaho National Laboratory.

BWX Technologies, Inc. (NYSEBWXT) ("BWXT", "we", "us" or the "Company") reported first quarter 2022 revenue of $531 million, a slight increase compared with $528 million in the first quarter 2021. GAAP net income for the first quarter 2022 was $59.0 million, or $0.64 per diluted share, compared with GAAP net income of $69.7 million, or $0.73 per diluted share, in the prior-year period. Non-GAAP(1) net income for the first quarter 2022 was $63.0 million, or $0.69 per diluted share. Consolidated adjusted EBITDA(1) for the first quarter 2022 was $94.4 million, a 4% decrease compared with the prior-year period of $98.3 million, primarily driven by lower recoverable CAS pension income and fewer favorable contract adjustments due to lower productivity in the naval reactors business. A reconciliation of non-GAAP results are detailed in Exhibit 1.

BWX Technologies, Inc. (NYSEBWXT) announced today that Jan A. Bertsch has been elected as its new chair of the board of directors, effective May 3, 2022, succeeding retiring board chairman John A. Fees.

BWX Technologies, Inc. (BWXT) (NYSEBWXT) will issue a press release detailing first quarter 2022 results on Monday, May 9, 2022, after market close and will host a conference call at 5:00 p.m. EDT.

BWX Technologies, Inc. (NYSEBWXT) today announced the release of its 2022 Sustainability Report. The report reviews the company’s environmental, social and governance (ESG) achievements and describes how BWXT uses its nuclear expertise to deliver safe and effective solutions to address some of the world’s most important problems in areas as diverse as global security, clean energy, environmental restoration, nuclear medicine and space exploration.

BWX Technologies, Inc. (NYSEBWXT) announced today that the U.S. Naval Nuclear Propulsion Program has exercised contract options totaling approximately $1 billion for manufacturing naval nuclear reactor components and fuel.

BWX Technologies, Inc. (NYSEBWXT) announced today that it has streamlined its reporting segment structure to better reflect its operations and position the company for improved efficiency and strategic growth. Starting with the first quarter of 2022, BWXT will report as two operating segments called Government Operations and Commercial Operations. The company has named Kevin M. McCoy president of the Government Operations segment, and John R. MacQuarrie president of the Commercial Operations segment.

BWX Technologies, Inc. (NYSEBWXT) ("BWXT", "we", "us" or the "Company") reported fourth quarter 2021 revenue of $592 million, a 6% increase compared with $557 million in the fourth quarter 2020. GAAP net income for the fourth quarter 2021 was $117 million, or $1.26 per diluted share, compared with GAAP net income of $65.7 million, or $0.69 per diluted share, in the prior-year period. Non-GAAP net income for the fourth quarter 2021 was $88.2 million, or $0.95 per diluted share, compared with non-GAAP net income of $70.9 million, or $0.74 per diluted share, in the prior-year period.

BWX Technologies, Inc. (BWXT) (NYSEBWXT) will issue a press release detailing fourth quarter and full-year 2021 results on Tuesday, February 22, 2022, after market close and will host a conference call at 5:00 p.m. EST.

BWX Technologies, Inc. (NYSEBWXT) is hosting an Investor Day 8:30 a.m. to approximately 11:30 a.m. ET on Tuesday, Nov. 16, 2021.

BWX Technologies, Inc. (NYSEBWXT) announced today that as part of BWXT’s executive succession planning process, Robb A. LeMasters has been named senior vice president and chief financial officer effective November 15, 2021. LeMasters will succeed David S. Black, who will retire after 30 years of service to BWXT.